Boehringer Ingelheim India Private Limited — Empagliflozin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Empagliflozin · $681.8K export value · DGFT Verified
Boehringer Ingelheim India Private Limited is the #2 Indian exporter of Empagliflozin with $681.8K in export value and 28 verified shipments. Boehringer Ingelheim India Private Limited holds a 10.2% market share in Empagliflozin exports across 2 countries. The company exports 2 pharmaceutical products worth $772.3K across 2 therapeutic categories.
Boehringer Ingelheim India Private Limited — Empagliflozin Export Profile: Buyers & Destinations
Where Does Boehringer Ingelheim India Private Limited Export Empagliflozin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $457.0K | 19 | 77.3% |
| NEPAL | $133.9K | 9 | 22.7% |
Boehringer Ingelheim India Private Limited exports Empagliflozin to 2 countries. The largest destination is SRI LANKA accounting for 77.3% of Boehringer Ingelheim India Private Limited's Empagliflozin shipments. These destinations reflect Boehringer Ingelheim India Private Limited's established distribution network and regulatory approvals in key markets.